Sanofi SA
XBER:SNW
Sanofi SA
XBER:SNW
Price:
82.48
EUR
Market Cap:
€103.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sanofi SA
XBER:SNW
|
FR |
|
Pure Energy Minerals Ltd
XTSX:PE
|
CA |
|
E
|
Emeren Group Ltd
BMV:SOLN
|
US |
|
N
|
Nantong Chaoda Equipment Co Ltd
SZSE:301186
|
CN |
|
HP Inc
NYSE:HPQ
|
US |
|
H
|
Havsfrun Investment AB
STO:HAV B
|
SE |
|
A
|
Alibaba Health Information Technology Ltd
OTC:ALBBY
|
HK |
|
QuoteMedia Inc
OTC:QMCI
|
US |
|
N
|
Nisshinbo Holdings Inc
F:NBO
|
JP |
Multiples-Based Value
The Multiples-Based Value of one
SNW
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 82.48 EUR,
Sanofi SA
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SNW Multiples-Based Value
LOCKED
Multiples Across Competitors
SNW Competitors Multiples
Sanofi SA Competitors
Sanofi SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
XBER:SNW
|
97.1B EUR | 2.1 | 12.4 | 10.4 | 10.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD | 13.4 | 42.2 | 28.5 | 30.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.2B USD | 6.1 | 21.3 | 14.8 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.4 | 15.8 | 9.8 | 12 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
158.2B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.4B USD | 2.4 | 16.6 | 7 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
